about
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroAmplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.Targeting PI3K/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT.AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations.
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ondrej Kalous
@ast
Ondrej Kalous
@en
Ondrej Kalous
@es
Ondrej Kalous
@nl
Ondrej Kalous
@sl
type
label
Ondrej Kalous
@ast
Ondrej Kalous
@en
Ondrej Kalous
@es
Ondrej Kalous
@nl
Ondrej Kalous
@sl
prefLabel
Ondrej Kalous
@ast
Ondrej Kalous
@en
Ondrej Kalous
@es
Ondrej Kalous
@nl
Ondrej Kalous
@sl
P106
P31
P496
0000-0002-3821-6603